- Home
- NNNN vs EVGO Comparison
NNNN vs EVGO Comparison
Compare NNNN & EVGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNNN
- EVGO
- Stock Information
- Founded
- NNNN 2021
- EVGO 2010
- Country
- NNNN Germany
- EVGO United States
- Employees
- NNNN N/A
- EVGO N/A
- Industry
- NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- EVGO Other Specialty Stores
- Sector
- NNNN Health Care
- EVGO Consumer Discretionary
- Exchange
- NNNN Nasdaq
- EVGO Nasdaq
- Market Cap
- NNNN 369.6M
- EVGO 376.5M
- IPO Year
- NNNN 2025
- EVGO N/A
- Fundamental
- Price
- NNNN $16.10
- EVGO $4.03
- Analyst Decision
- NNNN
- EVGO Strong Buy
- Analyst Count
- NNNN 0
- EVGO 10
- Target Price
- NNNN N/A
- EVGO $6.00
- AVG Volume (30 Days)
- NNNN 78.0K
- EVGO 5.0M
- Earning Date
- NNNN 01-01-0001
- EVGO 07-31-2025
- Dividend Yield
- NNNN N/A
- EVGO N/A
- EPS Growth
- NNNN N/A
- EVGO N/A
- EPS
- NNNN 0.06
- EVGO N/A
- Revenue
- NNNN $8,185,146.00
- EVGO $276,954,000.00
- Revenue This Year
- NNNN N/A
- EVGO $41.36
- Revenue Next Year
- NNNN N/A
- EVGO $33.67
- P/E Ratio
- NNNN $286.95
- EVGO N/A
- Revenue Growth
- NNNN 21.95
- EVGO 45.15
- 52 Week Low
- NNNN $5.18
- EVGO $1.95
- 52 Week High
- NNNN $18.50
- EVGO $9.07
- Technical
- Relative Strength Index (RSI)
- NNNN N/A
- EVGO 58.89
- Support Level
- NNNN N/A
- EVGO $3.76
- Resistance Level
- NNNN N/A
- EVGO $4.80
- Average True Range (ATR)
- NNNN 0.00
- EVGO 0.23
- MACD
- NNNN 0.00
- EVGO -0.00
- Stochastic Oscillator
- NNNN 0.00
- EVGO 51.79
About NNNN Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
About EVGO EVgo Inc.
EVgo owns and operates a public direct current fast-charging network in the US. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the US. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.